ADVISORY BOARD

 
 
 
MLabroad.jpeg

Michael LaBroad

Michael has been consistently ranked as one of America’s top marketing and branding experts for over 20 years. He is the only Brand Week honoree to receive their highest award for 3 different brands within three different companies. Michael has successful experience at the highest marketing and branding levels at some of America’s most popular and dynamic brands like Budweiser, SeaWorld, Bass Pro Shops, The National Hockey League, Rural Media Group and Burlington Capital.  

Michael is often asked to consult and advise on mergers and acquisitions, innovations, rebranding and upstarts. His success is based upon the foundational understanding that people make emotional decisions first and then intellectualize them. When this is fully comprehended and a plan is built around it, the measurable results will be exponential. 

 
 
willson.png

Denny Willson

Denny Willson is President & CEO of ITF Pharma, Inc., an affiliate of Italfarmaco, S.p.A., a family-owned pharmaceutical company with operations in over 40 countries around the world. He was previously one of the founders of Hsiri Therapeutics, a start-up developer of novel antibiotics based on discoveries from the laboratories of Dr. Marvin Miller at the University of Notre Dame.  

 

Aaron Abend

Aaron Abend is software entrepreneur with 30 years of experience in database development, the last 15 focused on healthcare and medical research. He was cofounder of Recombinant Data, a software company that implemented database technologies for academic medical centers. The company experienced rapid growth from 2008 through 2012 as electronic health records were adopted across the country. The company was acquired by Deloitte Consulting in 2012 and after a 6 month transition period Aaron retired in 2013.

Aaron is best known for his work with Informatics for Integrating Biology and the Bedside, known as i2b2, an NIH funded, open-source software program that supports medical research by enabling HIPAA-compliant exploration of patient data. He has implemented i2b2 databases for research at dozens of academic medical centers around the country. He has also provided training in these technologies and has published work in the Journal of the American Medical Informatics Association (JAMIA).